Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Comprehensive Review of How to Weigh the Options, Select the Right Patients, and Maximize Benefits
Endocrine Practice - United States
doi 10.4158/ep-2018-0293
Full Text
Open PDFAbstract
Available in full text
Date
August 7, 2018
Authors
Publisher
AACE Corp (American Association of Clinical Endocrinologists)